Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2008

01.02.2008 | Original Paper

Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study

verfasst von: Hyun Joo Jang, Jung Han Kim, Hun Ho Song, Kyung Hee Woo, Mi Kim, Sea Hyub Kae, Jin Lee, Ji Wong Cho, Jung Hun Kang, Soon Il Lee, Soo Jung Gong, Jung Ae Lee, Dae Young Zang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

We investigated early postoperative morbidity, mortality, and long-term outcomes in patients with liver cirrhosis (LC) who had undergone curative surgery for gastric cancer. The medical records of patients with LC who had undergone radical gastrectomy for gastric adenocarcinoma between January 1996 and September 2006 were retrospectively reviewed. A total of 57 patients were enrolled in this study. Forty-six patients (81%) were classified into Child’s class A. In 22 patients (39%) postoperative complications developed, the most common being ascites (23%), followed by wound infection and hepatic encephalopathy. Postoperative ascites occurred more frequently in patients with Child’s class B or C than in those with class A (63.6% vs 13%, = 0.001). Massive ascites developed in 4 patients, 3 of whom had Child’s class B and underwent D2 lymph node (LN) dissection, and 1 of whom had Child’s class C and a D1 LN dissection. Postoperative mortality occurred in 5 patients (9%), with a significantly higher mortality rate for patients with Child’s class B or C than for those with class A (27.2% vs 4.3%, = 0.045). With a median follow-up of 32 months, the estimated 5-year survival rate for all patients was 54%. Regardless of the tumor depth, overall survival was longer for patients with Child’s class A than for those with Child’s class B or C. These results demonstrated that radical gastrectomy with extended LN dissection is feasible in patients with compensated LC. For patients with moderate to severe hepatic dysfunction, however, D1 or less extensive LN dissection may be the more reasonable surgical procedure.
Literatur
1.
Zurück zum Zitat Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr HC, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG (2002) Cancer incidence in Korea. Cancer Res Treatment 34:405–408 Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr HC, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG (2002) Cancer incidence in Korea. Cancer Res Treatment 34:405–408
2.
Zurück zum Zitat Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627PubMed Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627PubMed
3.
Zurück zum Zitat Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef
4.
Zurück zum Zitat Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R (1993) Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 25:473–476PubMed Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R (1993) Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 25:473–476PubMed
5.
Zurück zum Zitat Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, Morini S, Taggi F (2003) Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12:179–182PubMedCrossRef Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, Morini S, Taggi F (2003) Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12:179–182PubMedCrossRef
6.
Zurück zum Zitat Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, Poon RT, Wong J (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201PubMedCrossRef Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, Poon RT, Wong J (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201PubMedCrossRef
7.
Zurück zum Zitat Mansour A, Watson W, Shayani V, Pickleman J (1997) Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122:730–735PubMedCrossRef Mansour A, Watson W, Shayani V, Pickleman J (1997) Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122:730–735PubMedCrossRef
8.
Zurück zum Zitat Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N (1997) Surgery for gastric cancer in patients with liver cirrhosis. Surg Today 27:17–21PubMedCrossRef Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N (1997) Surgery for gastric cancer in patients with liver cirrhosis. Surg Today 27:17–21PubMedCrossRef
9.
Zurück zum Zitat Ryu KW, Lee JH, Kim YW, Park JW, Bae JM (2005) Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29:653–656PubMedCrossRef Ryu KW, Lee JH, Kim YW, Park JW, Bae JM (2005) Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29:653–656PubMedCrossRef
10.
Zurück zum Zitat Dumont AE, Mulholland JH (1962) Alteration in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann Surg 156:668–677PubMedCrossRef Dumont AE, Mulholland JH (1962) Alteration in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann Surg 156:668–677PubMedCrossRef
11.
Zurück zum Zitat Kumagai K (1998) Intractable ascites following surgery for gastric carcinoma. Surg 15:236–240 Kumagai K (1998) Intractable ascites following surgery for gastric carcinoma. Surg 15:236–240
12.
Zurück zum Zitat Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018PubMedCrossRef Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018PubMedCrossRef
13.
Zurück zum Zitat Takeda J, Hashimoto K, Tanaka T, Koufuji K, Kakegawa T (1992) Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology 39:433–436PubMed Takeda J, Hashimoto K, Tanaka T, Koufuji K, Kakegawa T (1992) Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology 39:433–436PubMed
Metadaten
Titel
Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study
verfasst von
Hyun Joo Jang
Jung Han Kim
Hun Ho Song
Kyung Hee Woo
Mi Kim
Sea Hyub Kae
Jin Lee
Ji Wong Cho
Jung Hun Kang
Soon Il Lee
Soo Jung Gong
Jung Ae Lee
Dae Young Zang
Publikationsdatum
01.02.2008
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2008
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9884-3

Weitere Artikel der Ausgabe 2/2008

Digestive Diseases and Sciences 2/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.